Marathon Capital Management Astrazeneca PLC Transaction History
Marathon Capital Management
- $387 Million
- Q4 2024
A detailed history of Marathon Capital Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Marathon Capital Management holds 168,090 shares of AZN stock, worth $13 Million. This represents 2.84% of its overall portfolio holdings.
Number of Shares
168,090
Previous 163,010
3.12%
Holding current value
$13 Million
Previous $12.7 Million
13.29%
% of portfolio
2.84%
Previous 3.19%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,365Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.66 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.17 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.9 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.86 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.86 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $239B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...